
Winter 2025
By Kayla McMahon
The Terri Brodeur Breast Cancer Foundation awarded $125,000 to Genevra Kuziel, PhD, supporting her research on estrogen receptor-positive (ER+) breast cancer, the most common breast cancer subtype with a high recurrence rate. Kuziel’s work aims to develop innovative combination therapies, with the goal of transforming treatment options and improving outcomes for patients.
